Company Overview
FIGS, Inc. operates as a direct-to-consumer healthcare apparel and lifestyle company, designing and selling specialized scrubwear alongside non-scrubwear offerings such as outerwear, underscrubs, footwear, and compression garments to the United States and international markets. The company functions within the Consumer Cyclical sector and the Apparel Manufacturing industry, positioning it among entities sensitive to discretionary spending and consumer fashion trends while maintaining a focus on the professional healthcare workforce. The firm employs approximately 330 people and holds a market capitalization of $2.36 billion, reflecting significant investor interest in its business model. With annual revenue reaching $631.10 million, these valuation and revenue figures indicate that FIGS, Inc. has established a substantial footprint in the healthcare apparel market, distinguishing it as a major player capable of generating substantial sales volume while maintaining a relatively lean operational structure compared to its financial scale.
Financial Health
The company reported revenue of $631.10 million over the trailing twelve months, generating net income of $34.25 million and EBITDA of $47.18 million, a disparity that reveals a significant cost structure where operating expenses consume a considerable portion of top-line growth before reaching the bottom line. Free cash flow stands at $45.60 million, which provides the company with strong financial flexibility to fund operations, manage working capital, or pursue strategic initiatives without relying heavily on external financing. The gross margin is reported at 66.5%, indicating high pricing power or efficient production costs relative to the cost of goods sold, while the operating margin of 9.3% and profit margin of 5.4% demonstrate the final efficiency of converting sales into operational earnings and net profit respectively. In terms of capital structure, the company holds $300.85 million in cash against $60.00 million in debt, supported by a debt-to-equity ratio of 13.72, which suggests a balance sheet that is highly conservative with substantial liquidity reserves far exceeding its obligations. The current ratio of 4.94 indicates robust short-term liquidity, meaning the company possesses nearly five times the current assets necessary to cover its current liabilities, ensuring it can meet immediate financial obligations comfortably. Return on Equity is 8.4% and Return on Assets is 4.4%, metrics that reveal management's effectiveness in generating returns from shareholder capital and utilizing the company's asset base to produce earnings, though the ROA suggests a moderate efficiency in asset utilization relative to the equity base.
Valuation Assessment
The stock carries a trailing P/E ratio of 74.79 and a forward P/E of 47.83, where the difference between these two figures implies that the market expects earnings growth to be significantly higher in the coming year than what has been achieved historically. The price-to-book ratio is 5.39, indicating that the market values the company at more than five times its book value, which suggests a significant premium assigned to its brand, intellectual property, or growth prospects rather than tangible assets alone. Alternative valuation metrics include a price-to-sales ratio of 3.75 and an EV/EBITDA of 45.00, figures that suggest investors are pricing the company based on future growth expectations rather than current asset replacement costs or immediate earnings power. Regarding price movement, the 52-week high is $17.48 and the 52-week low is $3.56, placing the current trading environment within a wide range that highlights the asset's volatility and recent momentum away from its historical lows. The beta value is 1.22, which means the stock's price volatility is roughly 22% higher than the broader market, indicating that the asset will likely experience larger swings in price relative to a standard market index during periods of increased market sentiment.
Growth & Income
Revenue growth over the year is 33.0% while earnings growth is 748.3%, demonstrating that earnings are expanding at a rate vastly faster than revenue, which implies significant leverage, one-time gains, or a major optimization of the cost structure that is amplifying profitability disproportionately to top-line expansion. As a non-dividend payer, the company has a dividend yield of N/A and a payout ratio of 0.0%, indicating that the firm reinvests all its earnings back into the business for growth rather than distributing cash to shareholders. This approach aligns with a capital allocation strategy focused on scaling operations and maintaining financial flexibility rather than providing passive income to investors. The overall growth and income profile is characterized by exceptional earnings acceleration and a total reinvestment of profits, positioning the company for expansion but offering no current yield for income-focused investors.